ReviewIndian journal of ophthalmology2017
Recent advances in corneal collagen cross-linking.
Review in Indian journal of ophthalmology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 30 citations in OpenAlex.
- Visual rehabilitation in keratoconus by altering corneal shape using the corneal crosslinking pen: initial results.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2025Trial
- One-Year Comparative Outcomes of Conventional Versus Accelerated Corneal Cross-Linking in Progressive Keratoconus.Medicina (Kaunas, Lithuania) · 2026Article
- Reactive oxygen species accelerated glycation for oxygen-independent corneal cross-linking.Frontiers in bioengineering and biotechnology · 2026Article
- Outcomes of localized corneal collagen crosslinking with a conventional device in progressive keratoconus.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2025Article
- Review
- Severe Complications after Corneal Collagen Cross-Linking (CXL).Klinische Monatsblatter fur Augenheilkunde · 2023Article
- A Bibliometric Analysis of 100 Most-Cited Articles on Corneal Cross-Linking.Frontiers in medicine · 2022Article
- A Prospective, Comparative, Clinical Study to Evaluate the Safety and Efficacy of Two Different 0.1% Riboflavin Solutions Used in Collagen Crosslinking Treatment for Patients with Keratoconus.Clinical ophthalmology (Auckland, N.Z.) · 2021Article
- A review of corneal biomechanics: Mechanisms for measurement and the implications for refractive surgery.Indian journal of ophthalmology · 2020Review
- Prospective 2-year study of accelerated pulsed transepithelial corneal crosslinking outcomes for Keratoconus.Eye (London, England) · 2019Article
- Long-term outcomes of riboflavin photodynamic antimicrobial therapy as a treatment for infectious keratitis.American journal of ophthalmology case reports · 2019Article
- Biomechanical Impact of Localized Corneal Cross-linking Beyond the Irradiated Treatment Area.Journal of refractive surgery (Thorofare, N.J. : 1995) · 2019Article
- Optimization of Extraction Conditions and Characterization of Pepsin-Solubilised Collagen from Skin of Giant Croaker (Nibea japonica).Marine drugs · 2018Article
- Three-Year Corneal Biomechanical Outcomes Assessed by CORVIS ST Dynamic Scheimpflug Imaging After Epithelium-Off Conventional Versus Accelerated Cross-Linking in Progressive Keratoconus.Romanian journal of ophthalmologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Corneal collagen cross-linking has become the preferred modality of treatment for corneal ectasia since its inception in late 1990s. Numerous studies have demonstrated the safety and efficacy of the conventional protocol. Our understanding of the cross-linking process is ever evolving, with its wide implications in the form of accelerated and pulsed protocols. Newer advancements in technology include various riboflavin formulations and the ability to deliver higher fluence protocols with customised irradiation patterns. A greater degree of customisation is likely the path forward, which will aim at achieving refractive improvements along with disease stability. The use of cross-linking for myopic correction is another avenue under exploration. Combination of half fluence cross-linking with refractive correction for high errors to prevent post LASIK regression is gaining interest. This review aims to highlight the various advancements in the cross-linking technology and its clinical applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.